Léčba natriuretickými peptidy – konec mýtu?
| Title in English | Natriuretic peptide treatment – the end of a myth? |
|---|---|
| Authors | |
| Year of publication | 2011 |
| Type | Article in Periodical |
| Magazine / Source | Remedia |
| MU Faculty or unit | |
| Citation | |
| Field | Cardiovascular diseases incl. cardiosurgery |
| Keywords | natriuretic peptides; heart failure; treatment |
| Description | An overview is presented of natriuretic peptides and their action in pathological conditions. The article describes the action and clinical use of nesiritide – a recombinant form of human B-type natriuretic peptide (hBNP) that is identical to endogenous B type natriuretic peptide (BNP). The therapeutic potential of omapatrilat, a novel endopeptidase inhibitor that prevents the degradation of natriuretic peptides, is also featured. |
| Related projects: |